Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Tuberculosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 348 articles:
HTML format



Single Articles


    January 2025

  1. Correction: Evaluation of TNF-alpha, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts.
    PLoS One. 2025;20:e0317538.
    PubMed     Abstract available


  2. HASSAN S, Yaesoubi R, Magnus OBH, Kanthali M, et al
    Factors associated with the delay in diagnosis of extrapulmonary tuberculosis at the patient and health system level: A study from a rural setting in India.
    PLoS One. 2025;20:e0316273.
    PubMed     Abstract available


  3. WONDIE WT, Wubneh CA, Legesse BT, Mekonen GB, et al
    Mortality and predictors among HIV-TB co-infected patients in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317048.
    PubMed     Abstract available


  4. XU XY, Zhou ZY, Gong LQ, Xu LQ, et al
    Spatial epidemiological analysis based on township scale and analysis of influencing factors of pulmonary tuberculosis cure of Changshu city from 2015 to 2022.
    PLoS One. 2025;20:e0317269.
    PubMed     Abstract available


  5. MUSYOKI VM, Mureithi M, Heikinheimo A, Maleche-Obimbo E, et al
    The impact of tuberculosis-induced hyperglycemia on pulmonary microbiota and airway mucus secretion in individuals not previously diabetic: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0316810.
    PubMed     Abstract available


  6. TILAHUN M, Wegayehu T, Wondale B, Gebresilase TT, et al
    Correction: Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    PLoS One. 2025;20:e0318279.
    PubMed     Abstract available


  7. DRUSZCZYNSKA M, Seweryn M, Wawrocki S, Pankowska A, et al
    Interferon (IFN)-gamma (gamma) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population.
    PLoS One. 2025;20:e0314400.
    PubMed     Abstract available


  8. BHEEMIREDDY S, Sowdhamini R, Srinivasan N
    Computational analysis of the effect of a binding protein (RbpA) on the dynamics of Mycobacterium tuberculosis RNA polymerase assembly.
    PLoS One. 2025;20:e0317187.
    PubMed     Abstract available


  9. MULUGETA KT, Dawed MY, Teklu SW
    Impact of media coverage on the transmission dynamics of TB with vaccines and treatment.
    PLoS One. 2025;20:e0314324.
    PubMed     Abstract available


  10. JAMA SS, Abdi MM
    Tuberculosis treatment outcomes and associated factors among patients treated at Bosaso TB Hospital, Bosaso, Somalia: A five-year retrospective study.
    PLoS One. 2025;20:e0314693.
    PubMed     Abstract available


  11. MAHAWAN N, Rattananupong T, Sri-Uam P, Jiamjarasrangsi W, et al
    Performance of five dynamic models in predicting tuberculosis incidence in three prisons in Thailand.
    PLoS One. 2025;20:e0318089.
    PubMed     Abstract available


  12. PERWITASARI DA, Faridah IN, Dania H, Setiawan D, et al
    Machine learning model to predict the adherence of tuberculosis patients experiencing increased levels of liver enzymes in Indonesia.
    PLoS One. 2025;20:e0315912.
    PubMed     Abstract available


  13. KIMULI D, Nakaggwa F, Namuwenge N, Kamara V, et al
    Level of tuberculosis-related stigma and associated factors in Ugandan communities.
    PLoS One. 2025;20:e0313750.
    PubMed     Abstract available


  14. HAMISI MA, Asri NAM, Yassim ASM, Suppian R, et al
    A systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials.
    PLoS One. 2025;20:e0317233.
    PubMed     Abstract available


  15. JOSHI L, Ponnana M, Sivangala R, Chelluri LK, et al
    Correction: Evaluation of TNF-alpha, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts.
    PLoS One. 2025;20:e0318949.
    PubMed     Abstract available


  16. GEBEYEHU EM, Mebratu A, Atnafu A, Hagos A, et al
    Process evaluation of Tuberculosis infection control and prevention practice at public health facilities in Tegede district, Northwest Ethiopia: Facility-based cross-sectional design.
    PLoS One. 2025;20:e0314514.
    PubMed     Abstract available


  17. BATISTA FAM, Araujo JIF, Soares FC, Schlosser TCM, et al
    Factors associated with pulmonary tuberculosis in elderly individuals: A protocol for a scoping review.
    PLoS One. 2025;20:e0318375.
    PubMed     Abstract available


  18. SIAME L, Chama GC, Masenga SK
    Correlates of tuberculosis in children under the age of 15 years.
    PLoS One. 2025;20:e0312570.
    PubMed     Abstract available


  19. MURPHY-OKPALA N, Eze C, Ossai EN, Agu CI, et al
    Enhancing programmatic scale-up: Applying the consolidated framework for implementation research to evaluate decentralized drug-resistant tuberculosis services in Southern Nigeria.
    PLoS One. 2025;20:e0318274.
    PubMed     Abstract available


  20. CANDELORO L, Savini L, Conte A, Calistri P, et al
    T-Racing: a modern tool for supporting epidemiological investigation in animal disease outbreaks in Italy.
    PLoS One. 2025;20:e0317313.
    PubMed     Abstract available


  21. SEID G, Alemu A, Diriba G, Hailu M, et al
    Active tuberculosis in household contacts of bacteriologically confirmed pulmonary tuberculosis patients: A multicenter study finding the 'Missed One' in Central Ethiopia.
    PLoS One. 2025;20:e0316903.
    PubMed     Abstract available


  22. TURYAHABWE S, Ramachandra SS, Quraishi S, Fasih I, et al
    A community based, bottom-up, multi-pronged, technology integrated approach to enhance tuberculosis related awareness and treatment adherence in Uganda: The ACTS model.
    PLoS One. 2025;20:e0318174.
    PubMed     Abstract available


  23. LING Y, Shen Y, Xu X, Yu G, et al
    Accuracy of next-generation sequencing for rapid diagnosis of tuberculous pleurisy: A protocol of systematic review and meta-analysis.
    PLoS One. 2025;20:e0319175.
    PubMed     Abstract available


  24. JINKS RC, Lesellier S, Smith F, Menzies FD, et al
    Evaluating sensitivity and specificity of the DPP Vet TB assay in badgers using Bayesian latent class models.
    PLoS One. 2025;20:e0313825.
    PubMed     Abstract available


  25. ARYA R, Shakya H, Chaurasia R, Kumar S, et al
    Correction: Computational reassessment of RNA-seq data reveals key genes in active tuberculosis.
    PLoS One. 2025;20:e0319694.
    PubMed     Abstract available


  26. COLLINS JM, Kipiani M, Jin Y, Sharma AA, et al
    Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.
    PLoS One. 2025;20:e0315999.
    PubMed     Abstract available


  27. CHITPIM N, Praditsitthikorn N, White LJ, Meeyai A, et al
    Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach.
    PLoS One. 2025;20:e0315772.
    PubMed     Abstract available


  28. LI X, Li Y, Guo L, Chen Y, et al
    Tuberculosis incidence, deaths and disability-adjusted life years in children and adolescence, 1990-2021: Results from the Global Burden of Disease Study 2021.
    PLoS One. 2025;20:e0317880.
    PubMed     Abstract available


  29. BIRU M, Datiko DG, Jerene D, Yohannes AG, et al
    Designing tuberculosis elimination framework through participatory processes in Ethiopia: Results from stakeholders' discussions.
    PLoS One. 2025;20:e0318209.
    PubMed     Abstract available


  30. ABOMA M, Abdisa B, Imana G, Taye K, et al
    Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia.
    PLoS One. 2025;20:e0319676.
    PubMed     Abstract available


  31. HUEDA-ZAVALETA M, de la Torre JCG, Barletta-Carrillo C, Tapia-Sequeiros G, et al
    Cytochemical analysis of cerebrospinal fluid in tuberculous meningitis versus other etiologies.
    PLoS One. 2025;20:e0318398.
    PubMed     Abstract available


  32. GRONNINGEN E, Nanyaro M, Ngadaya E, Mustafa T, et al
    Diagnostic and treatment delay in extrapulmonary tuberculosis and association with mortality: Experiences from Mbeya, Tanzania.
    PLoS One. 2025;20:e0320691.
    PubMed     Abstract available


  33. RIZZI A, Nucera E, Mazzucco W, Palumbo P, et al
    An interoperable web-based platform to support health surveillance against latent tuberculosis infection in health care workers and students: The evolution of CROSSWORD study protocol.
    PLoS One. 2025;20:e0319568.
    PubMed     Abstract available



  34. Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2025;20:e0321797.
    PubMed     Abstract available


  35. DODANI SK, Babar ZU, Mohammad KG, Ali S, et al
    Clinical presentation and outcome of tuberculosis in chronic kidney disease stage 4 & 5 from a high TB burden country.
    PLoS One. 2025;20:e0320907.
    PubMed     Abstract available


  36. LESTARI BW, Saptiningrum E, Huria L, Fikri AR, et al
    Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia.
    PLoS One. 2025;20:e0320401.
    PubMed     Abstract available


  37. WEI X, Liang D, Zhang Z, Thorpe KE, et al
    Active case finding using mobile vans with artificial intelligence aided radiology tests and sputum collection for rapid diagnostic tests to reduce tuberculosis prevalence among high-risk population in rural China: Protocol for a pragmatic trial.
    PLoS One. 2025;20:e0316073.
    PubMed     Abstract available


  38. MESERVE K, Chapman CA, Xu M, Zhou H, et al
    Multiplexed cytokine profiling identifies diagnostic signatures for latent tuberculosis and reactivation risk stratification.
    PLoS One. 2025;20:e0316648.
    PubMed     Abstract available


  39. TILAHUN M, Atnafu A, Gebresilase TT, Abebe M, et al
    Genotypic drug resistance and transmission clusters of Mycobacterium tuberculosis isolates among Ethiopian returnees from Saudi Arabia.
    PLoS One. 2025;20:e0318743.
    PubMed     Abstract available


  40. MUZEYI W, Babirekere E, Kalibbala D, Katamba A, et al
    Determinants and barriers in early tuberculosis treatment in children at a primary health care facility in Kampala, Uganda; A mixed methods study.
    PLoS One. 2025;20:e0321620.
    PubMed     Abstract available


  41. BALAKRISHNAN V, Kumaresan T, Surendra H, Allsop M, et al
    Developing and assessing MyTBCompanion - A tri-lingual integrated video observed therapy app for tuberculosis patient management in Malaysia and Indonesia.
    PLoS One. 2025;20:e0320394.
    PubMed     Abstract available


  42. KIM KY, Park YM, Ko SH, Han K, et al
    Baseline lung function and risk of incident tuberculosis: a nationwide population-based cohort study.
    PLoS One. 2025;20:e0322616.
    PubMed     Abstract available


  43. AGIZEW TB, Soka J, Mwimanzi S, Fast CD, et al
    The incremental value of tuberculosis detecting African giant pouched rats over Smear microscopy and Xpert MTB/RIF for Tanzanian TB detection.
    PLoS One. 2025;20:e0321866.
    PubMed     Abstract available


  44. ASARE-BAAH M, Johnston L, Dominique L, Lauzardo M, et al
    Timing and predictors of disease incidence among named contacts of reported tuberculosis patients in a low incidence setting.
    PLoS One. 2025;20:e0313801.
    PubMed     Abstract available


  45. CHEN ZK, Wu Z, Ye T, Lin CY, et al
    Exploring the accuracy of the Xpert MTB/RIF assay in detecting lymph node tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0321507.
    PubMed     Abstract available


  46. JIANG D, Qin L, Pan W, Yan S, et al
    The value of high-pitch scanning with Sn100kV and ADMIRE in CT examination of tuberculous destroyed lung: Identifying the optimal combination for ultra-low-dose imaging.
    PLoS One. 2025;20:e0322374.
    PubMed     Abstract available


  47. PUNGARTNIK PC, Viana PVS, Santos JPCD, Macedo LR, et al
    Spatial analysis of drug resistant tuberculosis (DRTB) incidence and relationships with determinants in Rio de Janeiro state, 2010 to 2022.
    PLoS One. 2025;20:e0321553.
    PubMed     Abstract available


  48. SHIN E, Yun JS, Lee YR, Cha HR, et al
    Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
    PLoS One. 2025;20:e0322147.
    PubMed     Abstract available


  49. BEYENE RA, Janse van Rensburg E
    Prevention and control of multidrug-resistance tuberculosis in Ethiopia: Patients' perspectives from the Oromia region.
    PLoS One. 2025;20:e0322054.
    PubMed     Abstract available


  50. NTSHIQA T, Velen K, Ginindza S, Nhlangulela L, et al
    Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa.
    PLoS One. 2025;20:e0318819.
    PubMed     Abstract available


  51. YIRENKYI SO, Taufik O, Laryea R, Acquah-Keelson A, et al
    Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB.
    PLoS One. 2025;20:e0323527.
    PubMed     Abstract available


  52. ZHOU Y, Anthony R, Wang S, Xia H, et al
    Understanding the epidemiology and pathogenesis of Mycobacterium tuberculosis with non-redundant pangenome of epidemic strains in China.
    PLoS One. 2025;20:e0324152.
    PubMed     Abstract available


  53. MCINZIBA A, Wademan DT, Zimri K, Jacobs S, et al
    Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South Africa.
    PLoS One. 2025;20:e0323492.
    PubMed     Abstract available


  54. MINJA LT, Minja LM, Mlalama K, Pamba D, et al
    Facilitators, barriers, and strategies for the implementation of peer-led tuberculosis active case finding among people who use drugs in Dar es Salaam, Tanzania.
    PLoS One. 2025;20:e0310069.
    PubMed     Abstract available


  55. AHMED FM, Girma M, Worku G, Tadesse T, et al
    Bovine tuberculosis in cattle slaughtered at Addis Ababa abattoir in Ethiopia and workforce awareness of zoonotic risk.
    PLoS One. 2025;20:e0321844.
    PubMed     Abstract available


  56. YANG C, Gao W, Guo Y, Zeng Y, et al
    Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens.
    PLoS One. 2025;20:e0324003.
    PubMed     Abstract available


  57. DONG THK, Canas LS, Donovan J, Beasley D, et al
    Convolutional neural network using magnetic resonance brain imaging to predict outcome from tuberculosis meningitis.
    PLoS One. 2025;20:e0321655.
    PubMed     Abstract available


  58. SHARMA N, Sharma N, Biswas A, Gupta S, et al
    Iron-restricted Mycobacterium tuberculosis exports pathogenicity factors packed in extracellular vesicles.
    PLoS One. 2025;20:e0324919.
    PubMed     Abstract available


  59. VANQA N, Viljoen L, Hoddinott G, Hesseling A, et al
    Lessons from a systematic tracing process aimed to reduce initial loss to follow-up (ILTFU) among people diagnosed with tuberculosis (TB) in Cape Town, South Africa.
    PLoS One. 2025;20:e0323943.
    PubMed     Abstract available


  60. MBUH TP, Amveilla AP, Mendjime P, Donkeng Donfack VF, et al
    Evaluating turnaround time to improve clients' satisfaction in the tuberculosis reference laboratory in Douala.
    PLoS One. 2025;20:e0323917.
    PubMed     Abstract available


  61. YAO L, Bu C, Xiang L
    The diagnostic accuracy of nanopore sequencing in Tuberculous Lymphadenitis: Systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0325370.
    PubMed     Abstract available


  62. SAINI P, Bhattacharyya S
    Impact of multiple consultations and switching in treatment-seeking in tuberculosis: Mathematical modelling and optimal control.
    PLoS One. 2025;20:e0324330.
    PubMed     Abstract available


  63. DE ZWAAN R, de Vries G, Ubbelohde E, Mulder A, et al
    Verification of emerging genomic mutations in Mycobacterium tuberculosis allows transmission chains to be distinguished in an epidemiological typing cluster extending over thirty years.
    PLoS One. 2025;20:e0319630.
    PubMed     Abstract available


  64. ZHOU Y, Lv X, Zhu S, Xu P, et al
    The characteristics of latent tuberculosis infection and its influencing factors in hospitalized patients in Suzhou, Jiangsu, China.
    PLoS One. 2025;20:e0322913.
    PubMed     Abstract available


  65. GAGNON S, Ametepe E, Point F, Cloutier Charette W, et al
    TBpore cluster: A novel phylogenetic pipeline for tuberculosis transmission studies using nanopore next-generation sequencing data.
    PLoS One. 2025;20:e0325914.
    PubMed     Abstract available


  66. STEIN R, Fastenau A, Aman H, Ortuno-Gutierrez N, et al
    Understanding stigma: The experiences of people with drug-sensitive pulmonary tuberculosis in Rawalpindi, Pakistan.
    PLoS One. 2025;20:e0324614.
    PubMed     Abstract available


  67. CORDEIRO DC, Kuabara P, Amaral BC, Portugal LM, et al
    Needs assessment and preparedness of the primary health care network for scaling-up preventive tuberculosis treatment in 5 Brazilian capitals.
    PLoS One. 2025;20:e0326428.
    PubMed     Abstract available


  68. SILVA RDD, Farias ERG, Graca JMBD, Pinheiro EMN, et al
    Approaches and results of intersectoral actions for tuberculosis control in the world: A scoping review.
    PLoS One. 2025;20:e0326784.
    PubMed     Abstract available


  69. BELHEOUANE M, Kalsdorf B, Niemann S, Gaede KI, et al
    Serratia sp. traits distinguish the lung microbiome of patients with tuberculosis and non-tuberculous mycobacterial lung diseases.
    PLoS One. 2025;20:e0325362.
    PubMed     Abstract available


  70. TAREKEGN TB, Alemkere G, Ali EE
    Health-Related Quality of Life measured with EQ-5D-5L among tuberculosis patients in Addis Ababa, Ethiopia: Institutional-based cross-sectional study.
    PLoS One. 2025;20:e0326033.
    PubMed     Abstract available


  71. KELLER S, Naidoo K, Zekarias M, Israel-Isah S, et al
    Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.
    PLoS One. 2025;20:e0326342.
    PubMed     Abstract available


  72. INTHAVONG D, Elsayed H, Keonakhone P, Seevisay V, et al
    The prevalence of undernutrition and associated risk factors in people with tuberculosis in Lao People's Democratic Republic.
    PLoS One. 2025;20:e0324838.
    PubMed     Abstract available


  73. S A, S S, K N, M M, et al
    Breaking barriers for TB elimination: A novel community-led strategy revolutionizing tuberculosis case finding and treatment support in Senapati District Manipur-A quasi-experimental pre-post study protocol.
    PLoS One. 2025;20:e0326324.
    PubMed     Abstract available


  74. JENNINGS K, Lembani M, Hesseling AC, Mbula N, et al
    Correction: A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa.
    PLoS One. 2025;20:e0327683.
    PubMed     Abstract available


  75. ZHANG F, Gao Y, Li T, Zhang W, et al
    Development and validation of a nomogram for predicting false negative IGRA results in pulmonary tuberculosis patients using propensity score matching.
    PLoS One. 2025;20:e0327767.
    PubMed     Abstract available


  76. NGMENBELLE D, Amoa-Saah B, Nimirkpen S, Akesem MA, et al
    Spatiotemporal hotspot analysis of tuberculosis lost to follow-up cases in Ghana: A district-level study from 2019-2023.
    PLoS One. 2025;20:e0326444.
    PubMed     Abstract available


  77. AHMED S, Biswas S, Rahman T, Adel ASS, et al
    Mixed-methods study to assess delay among patients with tuberculosis in an urban setting of Bangladesh.
    PLoS One. 2025;20:e0327348.
    PubMed     Abstract available


  78. FENWICK MK, DeRocher AE, Craig JK, Harmon EK, et al
    Crystal structures of Mycobacterium tuberculosis and Mycobacterium thermoresistibile glycyl-tRNA synthetases in various liganded states.
    PLoS One. 2025;20:e0326500.
    PubMed     Abstract available


  79. LI N, Wei W, Lao Y, Zhu X, et al
    Long-term trends and future projections of the burden of tuberculosis among children and adolescents in China.
    PLoS One. 2025;20:e0328255.
    PubMed     Abstract available


  80. TEIBO TKA, Berra TZ, Alves YM, Tavares RBV, et al
    Surveillance of tuberculosis incidence and mortality through spatio-temporal analysis in Oyo State, Nigeria.
    PLoS One. 2025;20:e0311739.
    PubMed     Abstract available


  81. MAGHRADZE N, Loiseau C, Goig GA, Bablishvili N, et al
    Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia.
    PLoS One. 2025;20:e0326794.
    PubMed     Abstract available


  82. ROBERTI J, Carmiol-Rodriguez P, Chan-Liang E, Aguilar-Vidrio OA, et al
    Enhancing tuberculosis treatment support: A thematic analysis of interactive messages in a digital adherence technology trial to identify needs, challenges, and strategies for improvement.
    PLoS One. 2025;20:e0326492.
    PubMed     Abstract available


  83. MAHALINGAM V, Malaisamy M, Daniel BD, Bhaskar A, et al
    Health related quality of life of tuberculosis patients in South India: A longitudinal assessment study.
    PLoS One. 2025;20:e0328484.
    PubMed     Abstract available


  84. GUPTA AJ, Turimumahoro P, Rosman L, Golub JE, et al
    Methodologies for studying depression in persons living with tuberculosis: Protocol for a scoping review.
    PLoS One. 2025;20:e0322753.
    PubMed     Abstract available


  85. SMITH GC, Budgey R
    Bovine tuberculosis model validation against a field study of badger vaccination with selective culling.
    PLoS One. 2025;20:e0320830.
    PubMed     Abstract available


  86. SHEWADE HD, Ravichandran P, Satish S, Pradeep SK, et al
    Effect of glycemic control and type of diabetes treatment on TB treatment outcomes among people with TB-diabetes: A systematic review (updated August 2024).
    PLoS One. 2025;20:e0328619.
    PubMed     Abstract available


  87. MERT A, Derin O, Zerdali E, Kaya A, et al
    Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Turkiye (2014-2024) ClinSurv HIV cohort: A large case series.
    PLoS One. 2025;20:e0329267.
    PubMed     Abstract available


  88. KUNJOK DM, Mwangi JG, Kairu-Wanyoike S, Kinyua J, et al
    Spatial epidemiology of tuberculosis diagnostic delays, healthcare access disparities, and socioeconomic inequities in Nairobi County, Kenya.
    PLoS One. 2025;20:e0329984.
    PubMed     Abstract available


  89. GALLEGATI M, Lopreite M, Puliga M
    Modeling the formation of a worldwide health network fighting TBC: Key drivers in policy, management and governance in developing countries and global health institutions.
    PLoS One. 2025;20:e0330538.
    PubMed     Abstract available


  90. MAENETJE N, Oladimeji M, Mlotshwa M, Hoft D, et al
    Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis.
    PLoS One. 2025;20:e0329562.
    PubMed     Abstract available


  91. SILVA JUNIOR JNB, Leal GDC, Ferreira QR, Andrade LKA, et al
    Effectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0330208.
    PubMed     Abstract available


  92. GARCIA-ZAMALLOA A, Arnay R, Castilla-Rodriguez I, Mar J, et al
    Machine learning for predicting the diagnosis of tuberculous versus malignant pleural effusion: External validation and accuracy in two different settings.
    PLoS One. 2025;20:e0329668.
    PubMed     Abstract available


  93. JARLSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Correction: Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2025;20:e0331721.
    PubMed     Abstract available


  94. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0327243.
    PubMed     Abstract available


  95. WEBER SF, Wolf R, Manten K, Thangakunam B, et al
    Lung and abdominal ultrasound accuracy for tuberculosis: An Indian prospective cohort study.
    PLoS One. 2025;20:e0329670.
    PubMed     Abstract available


  96. YISMAW L, Zewotir T, Muluneh EK, Getnet F, et al
    Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.
    PLoS One. 2025;20:e0331035.
    PubMed     Abstract available


  97. ZHANG R, Bao X, Bao F, Teng C, et al
    Evaluation of the Xpert MTB/XDR test for detection of isoniazid, fluoroquinolones, and second-line injectable drugs resistance to Mycobacterium tuberculosis-Anhui Province, China.
    PLoS One. 2025;20:e0331264.
    PubMed     Abstract available


  98. BA-IREDIRE E, Avoka JA, Abanga L, Darkie AA, et al
    Prevalence and factors influencing drug-resistant tuberculosis in four regions of Ghana.
    PLoS One. 2025;20:e0331958.
    PubMed     Abstract available


  99. YU Q, Yao R, Lei L, Shao X, et al
    A correlation analysis between nutritional status and physical function in the elderly with pulmonary tuberculosis.
    PLoS One. 2025;20:e0331700.
    PubMed     Abstract available


  100. RUEDAS-LOPEZ A, Herrero-Martinez JM, Reyes A, Gonzalez-Blanco B, et al
    Refining the diagnostic approach to latent tuberculosis Infection with Quantiferon gold plus: A retrospective analysis of borderline results.
    PLoS One. 2025;20:e0330345.
    PubMed     Abstract available


  101. HAYES MI, Ravishankar S, Qayum T, Nizet V, et al
    Transient vascular occlusions in a zebrafish model of mycobacterial brain infection.
    PLoS One. 2025;20:e0332161.
    PubMed     Abstract available


  102. DUBE TN, Mboniswa F, Qwana SE, Charalambous S, et al
    "If we lose it, we are worried": Individual and provider level perceptions towards weight change among people living with HIV who undergo TB screening in routine health care settings in Gauteng Province, South Africa.
    PLoS One. 2025;20:e0331904.
    PubMed     Abstract available


  103. NTSHIQA T, Fasanmi A, Nagudi J, Tsope L, et al
    Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings.
    PLoS One. 2025;20:e0332125.
    PubMed     Abstract available


  104. NAZNEEN A, Rahman T, Hossain A, Saha AK, et al
    Active case finding for tuberculosis in tea gardens of Bangladesh: A cross-sectional survey.
    PLoS One. 2025;20:e0333662.
    PubMed     Abstract available


  105. POUDEL S, Wagle L, Aryal TP, Adhikari B, et al
    Association between cardiometabolic risk factors and multidrug-resistant tuberculosis: A case-control study.
    PLoS One. 2025;20:e0333362.
    PubMed     Abstract available


  106. DUBE TN, Mboniswa F, de Groot L, Khumalo S, et al
    Acceptability of Digital Adherence Technologies to support people with drug-susceptible TB in South Africa.
    PLoS One. 2025;20:e0332103.
    PubMed     Abstract available


    January 2024
  107. VOLKMAN T, Muruganandah V, Graham H, Tosif S, et al
    QuantiFERON Gold-In-Tube for the diagnosis of mycobacterial tuberculosis infection in children under 5 years of age: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0295913.
    PubMed     Abstract available


  108. MUGENYI L, Namuwenge PM, Ouma S, Bakashaba B, et al
    Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda.
    PLoS One. 2024;19:e0296239.
    PubMed     Abstract available


  109. PEDRAZ T, Herrera L, Vazquez MC, Ramirez-Rubio O, et al
    The epidemiological situation of tuberculosis in Spain according to surveillance and hospitalization data, 2012-2020.
    PLoS One. 2024;19:e0295918.
    PubMed     Abstract available


  110. HAI BB, Anh TL, Thi Thu PN, Van HN, et al
    Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.
    PLoS One. 2024;19:e0295048.
    PubMed     Abstract available


  111. SPEKKER O, Kiss P A, Kis L, Kiraly K, et al
    White plague among the "forgotten people" from the Barbaricum of the Carpathian Basin-Cases with tuberculosis from the Sarmatian-period (3rd-4th centuries CE) archaeological site of Hodmezovasarhely-Kenyere-er, Bereczki-tanya (Hungary).
    PLoS One. 2024;19:e0294762.
    PubMed     Abstract available


  112. GUPTA A, Juneja S, Babawale V, Rustam Majidovich N, et al
    Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.
    PLoS One. 2024;19:e0296448.
    PubMed     Abstract available


  113. TESFAHUN HM, Al-Salihi L, Abdulkareem Al-Ani N, Mankhi AA, et al
    Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.
    PLoS One. 2024;19:e0296952.
    PubMed     Abstract available


  114. GIVE C, Morris C, Murray J, Jose B, et al
    Sociocultural understanding of Tuberculosis and implications for care-seeking among adults in the province of Zambezia, Mozambique: Qualitative research.
    PLoS One. 2024;19:e0289928.
    PubMed     Abstract available


  115. SANCHEZ-PEREZ HJ, Gordillo-Marroquin C, Vazquez-Marcelin J, Martin-Mateo M, et al
    Sociodemographic factors associated with the success or failure of anti-tuberculosis treatment in the Chiapas Highlands, Mexico, 2019-2022.
    PLoS One. 2024;19:e0296924.
    PubMed     Abstract available


  116. YAMANAKA T, Castro MC, Ferrer JP, Solon JA, et al
    Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.
    PLoS One. 2024;19:e0297342.
    PubMed     Abstract available


  117. SSEMASAAZI JA, Bongomin F, Akunzirwe R, Bayowa JR, et al
    Private practitioners' practices for tuberculosis management in a city largely served by the private health sector in Uganda.
    PLoS One. 2024;19:e0296422.
    PubMed     Abstract available


  118. CANTERA JL, Lillis LM, Peck RB, Moreau E, et al
    Correction: Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0297828.
    PubMed     Abstract available


  119. LAXMESHWAR C, Das M, Mathur T, Israni T, et al
    Correction: Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.
    PLoS One. 2024;19:e0298137.
    PubMed     Abstract available


  120. DAWOOD H, Yende-Zuma N, Singh U, Moodley MC, et al
    Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis.
    PLoS One. 2024;19:e0297224.
    PubMed     Abstract available


  121. WU Z, Li H, Wu J, Lai X, et al
    The profile of genome-wide DNA methylation, transcriptome, and proteome in streptomycin-resistant Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0297477.
    PubMed     Abstract available


  122. GERBER F, Semphere R, Lukau B, Mahlatsi P, et al
    Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi.
    PLoS One. 2024;19:e0288944.
    PubMed     Abstract available


  123. SIMIENEH A, Gashaneh S, Dereje R
    Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.
    PLoS One. 2024;19:e0298244.
    PubMed     Abstract available


  124. AJEMA AT, Simachew Y, Meshesha MD, Gari T, et al
    Time to tuberculosis development and its predictors among HIV-positive patients: A retrospective cohort study.
    PLoS One. 2024;19:e0298021.
    PubMed     Abstract available


  125. CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
    Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
    PLoS One. 2024;19:e0299477.
    PubMed     Abstract available


  126. POWELL SM, Jarsberg LG, Zionce ELM, Anderson LN, et al
    Longitudinal analysis of host protein serum signatures of treatment and recovery in pulmonary tuberculosis.
    PLoS One. 2024;19:e0294603.
    PubMed     Abstract available


  127. MESIC A, Khan WH, Lenglet A, Lynen L, et al
    Correction: Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
    PLoS One. 2024;19:e0299913.
    PubMed     Abstract available


  128. SERENE LG, Webber K, Champion PA, Schorey JS, et al
    Mycobacterium tuberculosis SecA2-dependent activation of host Rig-I/MAVs signaling is not conserved in Mycobacterium marinum.
    PLoS One. 2024;19:e0281564.
    PubMed     Abstract available


  129. OSMAN M, Meehan SA, von Delft A, Preez KD, et al
    Correction: Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2024;19:e0300768.
    PubMed     Abstract available


  130. CUNHA R, Filho DBM, M Albuquerque MFP, Lacerda HR, et al
    The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
    PLoS One. 2024;19:e0299244.
    PubMed     Abstract available


  131. KAUMBA PC, Siameka D, Kagujje M, Chungu C, et al
    Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.
    PLoS One. 2024;19:e0287876.
    PubMed     Abstract available


  132. APRIANI L, McAllister S, Sharples K, Aini IN, et al
    Tuberculin skin test and Interferon-gamma release assay agreement, and associated factors with latent tuberculosis infection, in medical and nursing students in Bandung, Indonesia.
    PLoS One. 2024;19:e0299874.
    PubMed     Abstract available


  133. JOBARTEH T, Otu J, Gitteh E, Mendy FS, et al
    The use of Kudoh method for culture of Mycobacterium tuberculosis and Mycobacterium africanum in The Gambia.
    PLoS One. 2024;19:e0300042.
    PubMed     Abstract available


  134. PADHI A, Agarwal A, Bhise M, Chaudhary A, et al
    Progress and challenges in achieving tuberculosis elimination in India by 2025: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0301060.
    PubMed     Abstract available


  135. MUNSHI T, Gupta A, Evangelopoulos D, Guzman JD, et al
    Correction: Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0301375.
    PubMed     Abstract available


  136. PETRUCCIANI A, Hoerter A, Kotze L, Du Plessis N, et al
    In silico agent-based modeling approach to characterize multiple in vitro tuberculosis infection models.
    PLoS One. 2024;19:e0299107.
    PubMed     Abstract available


  137. PERESU E, De Graeve D, Heunis JC, Kigozi NG, et al
    Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.
    PLoS One. 2024;19:e0301507.
    PubMed     Abstract available


  138. CAI N, Luo W, Ding L, Chen L, et al
    Obesity-related indicators and tuberculosis: A Mendelian randomization study.
    PLoS One. 2024;19:e0297905.
    PubMed     Abstract available


  139. OMONGOT S, Muttamba W, Najjingo I, Baruch Baluku J, et al
    Strategies to resolve the gap in adolescent tuberculosis care at four health facilities in Uganda: The teenager's TB pilot project.
    PLoS One. 2024;19:e0286894.
    PubMed     Abstract available


  140. CRUZ MARTINEZ OA, Garcia I, Puerto GM, Alvis-Zakzuk NJ, et al
    Tuberculosis patients face high treatment support costs in Colombia, 2021.
    PLoS One. 2024;19:e0296250.
    PubMed     Abstract available


  141. OTIENO J, Luciani A, Lumumba S, Gikunda G, et al
    Mental health issues associated with the management of tuberculosis in Homabay, Busia and Kakamega Counties, Kenya.
    PLoS One. 2024;19:e0298268.
    PubMed     Abstract available


  142. PAULOWSKI L, Filip R, Jankovic Makek M, Guglielmetti L, et al
    Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.
    PLoS One. 2024;19:e0291404.
    PubMed     Abstract available


  143. HIRSCH-MOVERMAN Y, Hsu A, Abrams EJ, Killam WP, et al
    Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries.
    PLoS One. 2024;19:e0296993.
    PubMed     Abstract available


  144. GONZALEZ-REYES R, Katz D, Lambert L, Sorri Y, et al
    Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017.
    PLoS One. 2024;19:e0298628.
    PubMed     Abstract available


  145. O'BRIEN A, Hayton A, Cutler K, Adler A, et al
    Diagnostic accuracy of the Enferplex Bovine TB antibody test using individual milk samples from cattle.
    PLoS One. 2024;19:e0301609.
    PubMed     Abstract available


  146. LIU CW, Wu LS, Lin CJ, Wu HC, et al
    Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3.
    PLoS One. 2024;19:e0303431.
    PubMed     Abstract available


  147. CHOI Y, Kim IK, Kim SJ, Kim HS, et al
    Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
    PLoS One. 2024;19:e0303050.
    PubMed     Abstract available


  148. BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
    PLoS One. 2024;19:e0300731.
    PubMed     Abstract available



  149. Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
    PLoS One. 2024;19:e0303549.
    PubMed    


  150. CHAND AB, Basnet A, Maharjan B, Rai G, et al
    Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    PLoS One. 2024;19:e0301210.
    PubMed     Abstract available


  151. ARCONADA ALVAREZ SJ, Hoover AT, Greenleaf M, Ray SM, et al
    "An app is just available at all times"-the process and outcomes of converting the Georgia Tuberculosis Reference Guide into a mobile application.
    PLoS One. 2024;19:e0298758.
    PubMed     Abstract available


  152. YENEW B, Kebede A, Alemu A, Diriba G, et al
    Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
    PLoS One. 2024;19:e0303460.
    PubMed     Abstract available


  153. MOMANYI RK, Kwobah EK, Owiti P, Nyamogoba H, et al
    Psychiatric morbidity among patients on treatment for tuberculosis at a tertiary referral hospital in Western Kenya.
    PLoS One. 2024;19:e0302744.
    PubMed     Abstract available


  154. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    PubMed     Abstract available


  155. OPITO R, Kwenya K, Ssentongo SM, Kizito M, et al
    Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study.
    PLoS One. 2024;19:e0300916.
    PubMed     Abstract available


  156. RICKMAN HM, Phiri MD, Feasey HRA, Mbale H, et al
    Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.
    PLoS One. 2024;19:e0291215.
    PubMed     Abstract available


  157. HAYRE K, Takele MK, Birri DJ
    Tuberculosis treatment outcomes and associated factors at Alemgena Health Center, Sebeta, Oromia, Ethiopia.
    PLoS One. 2024;19:e0303797.
    PubMed     Abstract available


  158. SZEKELY R, Sossen B, Mukoka M, Muyoyeta M, et al
    Prospective multicentre accuracy evaluation of the FUJIFILM SILVAMP TB LAM test for the diagnosis of tuberculosis in people living with HIV demonstrates lot-to-lot variability.
    PLoS One. 2024;19:e0303846.
    PubMed     Abstract available


  159. ABEBE M, Atnafu A, Tilahun M, Sero N, et al
    Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    PLoS One. 2024;19:e0304507.
    PubMed     Abstract available


  160. SONG Y, Zhao B, Wang S, Zheng Y, et al
    Proficiency of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China, 2008-2021.
    PLoS One. 2024;19:e0304265.
    PubMed     Abstract available


  161. AMUGE PM, Becker GL, Ssebunya RN, Nalumansi E, et al
    Patient characteristics and predictors of mortality among children hospitalised with tuberculosis: A six-year case series study in Uganda.
    PLoS One. 2024;19:e0301107.
    PubMed     Abstract available


  162. YU G, Xu X, Shen Y, Fang B, et al
    Diagnostic accuracy of nanopore sequencing for the rapid diagnosis of pulmonary tuberculosis: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0304162.
    PubMed     Abstract available


  163. DIPPENAAR A, Costa Conceicao E, Wells F, Loubser J, et al
    Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry.
    PLoS One. 2024;19:e0303938.
    PubMed     Abstract available


  164. PUYEN ZM, Santos-Lazaro D, Vigo AN, Cotrina VV, et al
    Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
    PLoS One. 2024;19:e0304130.
    PubMed     Abstract available


  165. DEKU JG, Aninagyei E, Bedzina I, Nudo G, et al
    Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana.
    PLoS One. 2024;19:e0305161.
    PubMed     Abstract available


  166. KETER AK, Vanobberghen F, Lynen L, Van Heerden A, et al
    Simultaneous alleviation of verification and reference standard biases in a community-based tuberculosis screening study using Bayesian latent class analysis.
    PLoS One. 2024;19:e0305126.
    PubMed     Abstract available


  167. AHIMBISIBWE I, Tumusiime C, Muteebwa L, Mupere E, et al
    Prevalence of pulmonary tuberculosis among casual labourers working in selected road construction sites in central Uganda.
    PLoS One. 2024;19:e0304719.
    PubMed     Abstract available


  168. FARIA MGBF, Andrade RLP, Leite KFS, Bonfim RO, et al
    Operational indicators for pulmonary tuberculosis diagnosis in people living with HIV before and after Xpert MTB/RIF implementation in the state of Sao Paulo, Brazil.
    PLoS One. 2024;19:e0305063.
    PubMed     Abstract available


  169. GUTKA HJ, Bondoc JMG, Patwell R, Khan S, et al
    Rv0100: An essential acyl carrier protein from M. tuberculosis important in dormancy.
    PLoS One. 2024;19:e0304876.
    PubMed     Abstract available


  170. ARYA R, Shakya H, Chaurasia R, Kumar S, et al
    Computational reassessment of RNA-seq data reveals key genes in active tuberculosis.
    PLoS One. 2024;19:e0305582.
    PubMed     Abstract available


  171. PEREZ-MARTINEZ DE, Zenteno-Cuevas R
    SNPs in genes related to the repair of damage to DNA in clinical isolates of M. tuberculosis: A transversal and longitudinal approach.
    PLoS One. 2024;19:e0295464.
    PubMed     Abstract available


  172. XIAN X, Li L, Ye J, Mo W, et al
    Betaine and I-LG may have a predictive value for ATB: A causal study in a large European population.
    PLoS One. 2024;19:e0306752.
    PubMed     Abstract available


  173. KASSAW A, Asferie WN, Azmeraw M, Kefale D, et al
    Incidence and predictors of tuberculosis among HIV-infected children after initiation of antiretroviral therapy in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0306651.
    PubMed     Abstract available


  174. PALACIOS CF, Chowdhary V, Hao R, Danve A, et al
    Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?
    PLoS One. 2024;19:e0306337.
    PubMed     Abstract available


  175. MAHAWAN N, Rattananupong T, Sri-Uam P, Jiamjarasrangsi W, et al
    Assessment of tuberculosis transmission probability in three Thai prisons based on five dynamic models.
    PLoS One. 2024;19:e0305264.
    PubMed     Abstract available


  176. DLANGALALA T, Musekiwa A, Mashamba-Thompson T
    Quality of TB diagnostic services at primary healthcare clinics in eThekwini district, South Africa.
    PLoS One. 2024;19:e0307149.
    PubMed     Abstract available


  177. SHEN Y, Ling Y, Yu G, Zhang X, et al
    The value of nanopore sequencing as a diagnostic tool in tuberculous meningitis: A protocol of systematic review and meta-analysis.
    PLoS One. 2024;19:e0307389.
    PubMed     Abstract available


  178. ZAKARIA WMZ, Mansor Z
    Intention to receive Latent Tuberculosis Infection (LTBI) treatment and its associated factors among healthcare workers in a Malaysian teaching university hospital.
    PLoS One. 2024;19:e0307199.
    PubMed     Abstract available


  179. RODRIGUEZ-MIGUEZ Y, Lozano-Ordaz V, Ortiz-Cabrera AE, Barrios-Payan J, et al
    Effect of IL-17A on the immune response to pulmonary tuberculosis induced by high- and low-virulence strains of Mycobacterium bovis.
    PLoS One. 2024;19:e0307307.
    PubMed     Abstract available


  180. MAHAPATRA A, Thiruvengadam K, Nair D, Padmapriyadarsini C, et al
    Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach.
    PLoS One. 2024;19:e0305855.
    PubMed     Abstract available


  181. CHEKESA B, Singh H, Gonzalez-Juarbe N, Vashee S, et al
    Pangenome and genomic signatures linked to the dominance of the lineage-4 of Mycobacterium tuberculosis isolated from extrapulmonary tuberculosis patients in western Ethiopia.
    PLoS One. 2024;19:e0304060.
    PubMed     Abstract available


  182. WILKINSON T, Garcia-Prats AJ, Sachs T, Paradkar M, et al
    Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines.
    PLoS One. 2024;19:e0305930.
    PubMed     Abstract available


  183. ALEXANDER FC, Mshiu JJ, Rushaigo AM, Mgina EJ, et al
    Knowledge of Tuberculosis preventive treatment among people living with HIV: A cross-sectional survey in selected regions of Tanzania.
    PLoS One. 2024;19:e0307670.
    PubMed     Abstract available


  184. NASIR A, Hassan II, Ma'ruf A, Suharno NE, et al
    Coping efforts made: Psychological burden of people living with tuberculosis due to social stigma in society. A qualitative phenomenology study.
    PLoS One. 2024;19:e0303331.
    PubMed     Abstract available


  185. CHERKOS AS, LaCourse SM, Enquobahrie DA, Escudero JN, et al
    Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.
    PLoS One. 2024;19:e0293708.
    PubMed     Abstract available


  186. YAN AJ, Olson AM, Weigel KM, Luabeya AK, et al
    Detection of Mycobacterium tuberculosis from tongue swabs using sonication and sequence-specific hybridization capture.
    PLoS One. 2024;19:e0308235.
    PubMed     Abstract available


  187. WEI G, Zhang J, Qiu X
    Application value of volumetric CT value in quantifying the activity of a pulmonary tuberculoma.
    PLoS One. 2024;19:e0306875.
    PubMed     Abstract available


  188. MARTINS N, Soares D, Gusmao C, Nunes M, et al
    A qualitative exploration of the impact of the COVID-19 pandemic on gender-based violence against women living with HIV or tuberculosis in Timor Leste.
    PLoS One. 2024;19:e0306106.
    PubMed     Abstract available


  189. ALSULAIS FM, Alhaidhal BA, Mothana RA, Alanzi AR, et al
    Identification of echinoderm metabolites as potential inhibitors targeting wild-type and mutant forms of Escherichia coli RNA polymerase (RpoB) for tuberculosis treatment.
    PLoS One. 2024;19:e0304587.
    PubMed     Abstract available


  190. REQUENA D, Supo-Escalante RR, Sheen P, Zimic M, et al
    Studying the dynamics of the drug processing of pyrazinamide in Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0309352.
    PubMed     Abstract available


  191. KRIVOSOVA M, Dohal M, Masiarova S, Prso K, et al
    Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention.
    PLoS One. 2024;19:e0305158.
    PubMed     Abstract available


  192. RETA MA, Asmare Z, Sisay A, Gashaw Y, et al
    Prevalence of pulmonary tuberculosis among key and vulnerable populations in hotspot settings of Ethiopia. A systematic review and meta-analysis.
    PLoS One. 2024;19:e0309445.
    PubMed     Abstract available


  193. FRITSCHI N, Gureva T, Eliseev P, Jackson C, et al
    Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study.
    PLoS One. 2024;19:e0293272.
    PubMed     Abstract available


  194. TOROKAA PR, Majigo MV, Kileo H, Urio L, et al
    The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB/RIF assay in Tanzania.
    PLoS One. 2024;19:e0296563.
    PubMed     Abstract available


  195. TESEMA E, Biru M, Leta T, Kumsa A, et al
    Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends.
    PLoS One. 2024;19:e0306076.
    PubMed     Abstract available


  196. RAFI MA, Semanta S, Shahriar T, Hasan MJ, et al
    An approach to integrated management of diabetes in tuberculosis patients: Availability and readiness of the health facilities of Bangladesh.
    PLoS One. 2024;19:e0309372.
    PubMed     Abstract available


  197. VERBOVEN L, Callens S, Black J, Maartens G, et al
    A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis.
    PLoS One. 2024;19:e0306101.
    PubMed     Abstract available


  198. SHI H, Zhu Y, Shang K, Tian T, et al
    Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approaches.
    PLoS One. 2024;19:e0307877.
    PubMed     Abstract available


  199. BLAKE E, Stringham E, Sloan-Aagard C
    Concurrent disease burden from multiple infectious diseases and the influence of social determinants in the contiguous United States.
    PLoS One. 2024;19:e0293431.
    PubMed     Abstract available


  200. PIRES DC, Arueira Chaves L, Dantas Cardoso CH, Faria LV, et al
    Effects of low dose computed tomography (LDCT) on lung cancer screening on incidence and mortality in regions with high tuberculosis prevalence: A systematic review.
    PLoS One. 2024;19:e0308106.
    PubMed     Abstract available


  201. JENNINGS K, Lembani M, Hesseling AC, Mbula N, et al
    A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa.
    PLoS One. 2024;19:e0310383.
    PubMed     Abstract available


  202. PENG Y, Li C, Hui X, Huo X, et al
    Phenotypic and genotypic analysis of drug resistance in M. tuberculosis isolates in Gansu, China.
    PLoS One. 2024;19:e0311042.
    PubMed     Abstract available


  203. AZIZ ZA, Mohamad AH, Mohamad Noordin N, Mohd Shariff N, et al
    Social-behavioral insights in understanding tuberculosis transmission pattern during the COVID-19 pandemic period in Kuala Lumpur, Malaysia: The MyTBNet study protocol.
    PLoS One. 2024;19:e0307921.
    PubMed     Abstract available


  204. YOON JY, Kim TO, Kim JS, Kim HW, et al
    Impact of pyrazinamide usage on serious adverse events in elderly tuberculosis patients: A multicenter cohort study.
    PLoS One. 2024;19:e0309902.
    PubMed     Abstract available


  205. NASIR BB, Muhammed OS, Tamiru MT, Chelkeba L, et al
    Assessing the impact of COVID-19 on tuberculosis detection and treatment in healthcare facilities across Addis Ababa, Ethiopia: A comprehensive mixed-method, multi-center study.
    PLoS One. 2024;19:e0311408.
    PubMed     Abstract available


  206. FROMENT A, Delomez J, Da Nascimento S, Dassonville-Klimpt A, et al
    Efficacy of mefloquine and its enantiomers in a murine model of Mycobacterium avium infection.
    PLoS One. 2024;19:e0311167.
    PubMed     Abstract available


  207. PRAPHAKORNMANO T, Torvorapanit P, Siranart N, Ohata PJ, et al
    The effect of corticosteroids in developing active pulmonary tuberculosis among patients with COVID-19.
    PLoS One. 2024;19:e0309392.
    PubMed     Abstract available


  208. AHAMED FAYAZ S, Babu L, Paridayal L, Vasantha M, et al
    Machine learning algorithms to predict treatment success for patients with pulmonary tuberculosis.
    PLoS One. 2024;19:e0309151.
    PubMed     Abstract available


  209. ATKINSON A, Kraus D, Banholzer N, Miro JM, et al
    HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015.
    PLoS One. 2024;19:e0312035.
    PubMed     Abstract available


  210. SHAFIPOUR M, Mohammadzadeh A, Mahmoodi P, Dehghanpour M, et al
    Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates.
    PLoS One. 2024;19:e0309292.
    PubMed     Abstract available


  211. NANDU N, Miller M, Tong Y, Lu ZX, et al
    A novel dual probe-based method for mutation detection using isothermal amplification.
    PLoS One. 2024;19:e0309541.
    PubMed     Abstract available


  212. MAHJABEEN A, Hasan MZ, Rahman MT, Islam MA, et al
    Genetic insights into the connection between pulmonary TB and non-communicable diseases: An integrated analysis of shared genes and potential treatment targets.
    PLoS One. 2024;19:e0312072.
    PubMed     Abstract available


  213. EVANS D, Hirasen K, Ramushu C, Long L, et al
    Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.
    PLoS One. 2024;19:e0309034.
    PubMed     Abstract available


  214. PELZER PT, Holleman M, Helinski MEH, Weinberg AL, et al
    The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa.
    PLoS One. 2024;19:e0292981.
    PubMed     Abstract available


  215. ZHU Y, Shi J, Wang Q, Zhu Y, et al
    Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.
    PLoS One. 2024;19:e0309560.
    PubMed     Abstract available


  216. SAMBAN SS, Kunoor A, Prasanna P, Krishnakumar M, et al
    Adopting a model of antimicrobial stewardship program to anti-tubercular treatment stewardship: A single-centre experience from a private tertiary care hospital in South India.
    PLoS One. 2024;19:e0310493.
    PubMed     Abstract available


  217. SHEWADE HD, Ravichandran P, Pradeep SK, Kiruthika G, et al
    Bridging the "know-do" gap to improve active case finding for tuberculosis in India: A qualitative exploration into national tuberculosis elimination program staffs' perspectives.
    PLoS One. 2024;19:e0309750.
    PubMed     Abstract available


  218. HICKMAN JH, Swartz A, Sicwebu N, Stek C, et al
    Exploring Health-Related Quality of Life (HRQOL) among patients with HIV-associated TB in Khayelitsha, South Africa.
    PLoS One. 2024;19:e0275554.
    PubMed     Abstract available


  219. OFFICER K, Arango-Sabogal JC, Dufour S, Lyashchenko KP, et al
    Bayesian accuracy estimates for diagnostic tests to detect tuberculosis in captive sun bears (Helarctos malayanus) and Asiatic black bears (Ursus thibetanus) in Cambodia and Vietnam.
    PLoS One. 2024;19:e0313007.
    PubMed     Abstract available


  220. TURINAWE G, Asaasira D, Kajumba MB, Mugumya I, et al
    Active tuberculosis disease among people living with HIV on ART who completed tuberculosis preventive therapy at three public hospitals in Uganda.
    PLoS One. 2024;19:e0313284.
    PubMed     Abstract available


  221. GIRMAY G, Kiflie A, Alem M, Lemma M, et al
    Human-immunodeficiency virus infection associated with the impaired Th1 and pro-inflammatory cytokine response in latent tuberculosis-infected individuals: A comparative cross-sectional study.
    PLoS One. 2024;19:e0313306.
    PubMed     Abstract available


  222. KASSAW A, Kefale D, Aytenew TM, Azmeraw M, et al
    Burden of mortality and its predictors among TB-HIV co-infected patients in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0312698.
    PubMed     Abstract available


  223. WARES DF, Mbenga M, Mirtskhulava V, Quelapio M, et al
    Introducing BPaL: Experiences from countries supported under the LIFT-TB project.
    PLoS One. 2024;19:e0310773.
    PubMed     Abstract available


  224. BRANDELLI COSTA A, Boeira LDS, de Almeida-Segundo DS, Chaves LW, et al
    Experiences and perspectives on rapid-test diagnosis of tuberculosis, histoplasmosis and cryptococcosis in people with advanced HIV/AIDS disease in Porto Alegre, Brazil.
    PLoS One. 2024;19:e0312204.
    PubMed     Abstract available


  225. IBRAHIM MAA, Mahmoud DGM, Abdelrahman AHM, Abdeljawaad KAA, et al
    Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulations.
    PLoS One. 2024;19:e0314422.
    PubMed     Abstract available


  226. CHUMCHUEN K, Wichaidit W, Chongsuvivatwong V
    Relationship between hospitalization from cannabis usage and pulmonary tuberculosis in Thailand from 2017 to 2022.
    PLoS One. 2024;19:e0312139.
    PubMed     Abstract available


  227. SYED RR, Catanzaro DG, Hillery N, Crudu V, et al
    Understanding tuberculosis transmission and progression: A prospective cohort study of index cases and close contacts in Moldova.
    PLoS One. 2024;19:e0313270.
    PubMed     Abstract available


  228. ELDUMA AH, Holakouie-Naieni K, Almasi-Hashiani A, Foroushani AR, et al
    Correction: The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
    PLoS One. 2024;19:e0314954.
    PubMed     Abstract available


  229. HUDA MH, Rahman MF, Zalaya Y, Mukminin MA, et al
    A meta-analysis of technology-based interventions on treatment adherence and treatment success among TBC patients.
    PLoS One. 2024;19:e0312001.
    PubMed     Abstract available


  230. KEMBABAZI V, Ssentongo J, Rutebemberwa E
    Facilitators and barriers to Tuberculosis case notification among private health facilities in Kampala Capital City, Uganda.
    PLoS One. 2024;19:e0315402.
    PubMed     Abstract available


  231. CISSE AB, Dean AS, Van Deun A, Keysers J, et al
    Prevalence of non-tuberculous mycobacteria among people with acid-fast positive presumptive tuberculosis in Mali.
    PLoS One. 2024;19:e0301731.
    PubMed     Abstract available


  232. SAMUEL V, Solomons R, Mason S
    Targeted metabolomics investigation of metabolic markers of Mycobacterium tuberculosis in the cerebrospinal fluid of paediatric patients with tuberculous meningitis.
    PLoS One. 2024;19:e0314854.
    PubMed     Abstract available


  233. SOARES TDS, Bello GL, Dos Santos Petry IM, Nicola MRC, et al
    Laboratory validation of a simplified DNA extraction protocol followed by a portable qPCR detection of M. tuberculosis DNA suitable for point of care settings.
    PLoS One. 2024;19:e0302345.
    PubMed     Abstract available


  234. WARIT S, Meesawat S, Cheawchanlertfa P, Makhao N, et al
    The new gamma interferon (IFN-gamma) algorithm for tuberculosis diagnosis in cynomolgus macaques.
    PLoS One. 2024;19:e0302349.
    PubMed     Abstract available


  235. AYELE TK, Doungmo Goufo EF, Mugisha S
    Co-infection mathematical model for HIV/AIDS and tuberculosis with optimal control in Ethiopia.
    PLoS One. 2024;19:e0312539.
    PubMed     Abstract available


  236. XIONG T, Qin W, Zhang Y, Chen Y, et al
    Prognostic nutritional index and naples prognostic score as biomarkers for the prognosis of incisional wound healing after thoracolumbar tuberculosis surgery.
    PLoS One. 2024;19:e0309267.
    PubMed     Abstract available


  237. PARVEEN A, Bhat SA, Elnaggar M, Meade KG, et al
    Comparative analysis of WC1.1+ and WC1.2+ gammadelta T cell subset responses from cattle naturally infected with Mycobacterium bovis to repeat stimulation with mycobacterial antigens.
    PLoS One. 2024;19:e0311854.
    PubMed     Abstract available


  238. LIMBERIS JD, Nagel RJ, Chakravorty S, Block D, et al
    stilPCR increases the effective sequencing length of Illumina targeted next-generation sequencing.
    PLoS One. 2024;19:e0314265.
    PubMed     Abstract available


  239. BAKULA Z, Wuyep VB, Bartocha L, Vyazovaya A, et al
    Correction: Molecular snapshot of drug-resistant Mycobacterium tuberculosis strains from the Plateau State, Nigeria.
    PLoS One. 2024;19:e0315611.
    PubMed     Abstract available


  240. MALHOTRA A, Thompson R, De Vos M, David A, et al
    Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
    PLoS One. 2024;19:e0316653.
    PubMed     Abstract available


  241. LATHAM AS, Geer CE, Ackart DF, Weninger KN, et al
    Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain.
    PLoS One. 2024;19:e0307577.
    PubMed     Abstract available


  242. GUTTA S, Mannam P, Kumar V, George T, et al
    Correction: Absence of posterior pituitary bright spot in adults with CNS tuberculosis: A case-control study.
    PLoS One. 2024;19:e0316921.
    PubMed     Abstract available


  243. NWOKOYE N, Ihesie A, Olabamiji J, Ochei K, et al
    Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study.
    PLoS One. 2024;19:e0316204.
    PubMed     Abstract available


  244. CAI N, Luo W, Ding L, Chen L, et al
    Correction: Obesity-related indicators and tuberculosis: A Mendelian randomization study.
    PLoS One. 2024;19:e0316856.
    PubMed     Abstract available


  245. OCHOLA EA, Mweu MM
    Performance of three diagnostic tests for tuberculosis among Human Immunodeficiency Virus (HIV) patients presenting to a health facility in an informal urban settlement in Nairobi, Kenya.
    PLoS One. 2024;19:e0307727.
    PubMed     Abstract available


    January 2023
  246. MONDAL R, Dusthackeer V N A, Kannan P, Singh AK, et al
    In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor.
    PLoS One. 2023;18:e0282454.
    PubMed     Abstract available


  247. KETER AK, Lynen L, Van Heerden A, Wong E, et al
    Evaluation of tuberculosis diagnostic test accuracy using Bayesian latent class analysis in the presence of conditional dependence between the diagnostic tests used in a community-based tuberculosis screening study.
    PLoS One. 2023;18:e0282417.
    PubMed     Abstract available


  248. MATJI R, Maama L, Roscigno G, Lerotholi M, et al
    Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019.
    PLoS One. 2023;18:e0273245.
    PubMed     Abstract available


  249. KHOR LA, A Wahid UNI, Ling LL, Liansim SMS, et al
    Prevalence and associated factors of delayed sputum smear conversion in patients treated for smear positive pulmonary tuberculosis: A retrospective follow up study in Sabah, Malaysia.
    PLoS One. 2023;18:e0282733.
    PubMed     Abstract available


  250. KIM S, Hesseling AC, Wu X, Hughes MD, et al
    Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household.
    PLoS One. 2023;18:e0283290.
    PubMed     Abstract available


  251. CASTLE AC, Hoeppner SS, Magodoro IM, Singh U, et al
    Association between prior tuberculosis disease and dysglycemia within an HIV-endemic, rural South African population.
    PLoS One. 2023;18:e0282371.
    PubMed     Abstract available


  252. MBUYA AW, Mboya IB, Semvua HH, Mamuya SH, et al
    Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania.
    PLoS One. 2023;18:e0280396.
    PubMed     Abstract available


  253. BRAZIER E, Maruri F, Wester CW, Musick B, et al
    Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
    PLoS One. 2023;18:e0268167.
    PubMed     Abstract available


  254. MATULYTE E, Davidaviciene E, Kancauskiene Z, Diktanas S, et al
    The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    PLoS One. 2023;18:e0282046.
    PubMed     Abstract available


  255. GEMECHU LL, Debusho LK
    Bayesian spatial modelling of tuberculosis-HIV co-infection in Ethiopia.
    PLoS One. 2023;18:e0283334.
    PubMed     Abstract available


  256. MOHAMMAD RAHIMI H, Javanmard E, Taghipour A, Haghighi A, et al
    Multigene typing of Giardia Duodenalis isolated from tuberculosis and non-tuberculosis subjects.
    PLoS One. 2023;18:e0283515.
    PubMed     Abstract available


  257. AMARE D, Getahun FA, Mengesha EW, Dessie G, et al
    Effectiveness of healthcare workers and volunteers training on improving tuberculosis case detection: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0271825.
    PubMed     Abstract available


  258. WILLGERT K, da Silva S, Li R, Dandapat P, et al
    Is bovine density and ownership associated with human tuberculosis in India?
    PLoS One. 2023;18:e0283357.
    PubMed     Abstract available


  259. MOYO N, Tay EL, Trauer JM, Burke L, et al
    Tuberculosis notifications in regional Victoria, Australia: Implications for public health care in a low incidence setting.
    PLoS One. 2023;18:e0282884.
    PubMed     Abstract available


  260. MOYO S, Ismail F, Mkhondo N, van der Walt M, et al
    Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017-2019.
    PLoS One. 2023;18:e0282125.
    PubMed     Abstract available


  261. SINHA S, Thukral H, Shareef I, Desai D, et al
    Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
    PLoS One. 2023;18:e0272682.
    PubMed     Abstract available


  262. MAYITO J, Martineau AR, Tiwari D, Nakiyingi L, et al
    Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study.
    PLoS One. 2023;18:e0281559.
    PubMed     Abstract available


  263. SUDCHAROEN A, Ruchikajorndech G, Srisajjakul S, Pongpaibul A, et al
    Clinical characteristics and diagnosis of intestinal tuberculosis in clinical practice at Thailand's largest national tertiary referral center: An 11-year retrospective review.
    PLoS One. 2023;18:e0282392.
    PubMed     Abstract available


  264. MARTINEZ-OLIVARES CE, Hernandez-Pando R, Mixcoha E
    In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
    PLoS One. 2023;18:e0284264.
    PubMed     Abstract available


  265. PARK S, Sung C, Choi H, Lee YW, et al
    Comparison of active tuberculosis case finding strategies for immigrants in South Korea: Epidemiology and cost-effectiveness analysis.
    PLoS One. 2023;18:e0283414.
    PubMed     Abstract available


  266. SIMMONS JD, Segnitz RM, Dill-McFarland KA, Stein CM, et al
    Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.
    PLoS One. 2023;18:e0284498.
    PubMed     Abstract available


  267. NGO DM, Doan NB, Tran SN, Hoang LB, et al
    Practice regarding tuberculosis care among physicians at private facilities: A cross-sectional study from Vietnam.
    PLoS One. 2023;18:e0284603.
    PubMed     Abstract available


  268. MOGA S, Bobosha K, Fikadu D, Zerihun B, et al
    Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    PLoS One. 2023;18:e0284737.
    PubMed     Abstract available


  269. SESSOLO A, Musisi E, Kaswabuli S, Zawedde J, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda.
    PLoS One. 2023;18:e0284041.
    PubMed     Abstract available


  270. ANDOM AT, Gilbert HN, Ndayizigiye M, Mukherjee JS, et al
    Understanding barriers to tuberculosis diagnosis and treatment completion in a low-resource setting: A mixed-methods study in the Kingdom of Lesotho.
    PLoS One. 2023;18:e0285774.
    PubMed     Abstract available


  271. GOROH MMD, van den Boogaard CHA, Lukman KA, Lowbridge C, et al
    Factors affecting implementation of tuberculosis contact investigation and tuberculosis preventive therapy among children in Sabah, East Malaysia: A qualitative study.
    PLoS One. 2023;18:e0285534.
    PubMed     Abstract available


  272. SILVA WCD, Camargo RNC Junior, Silva EBRD, Silva JARD, et al
    Perspectives of economic losses due to condemnation of cattle and buffalo carcasses in the northern region of Brazil.
    PLoS One. 2023;18:e0285224.
    PubMed     Abstract available


  273. BAENA A, Cabarcas F, Ocampo JC, Barrera LF, et al
    Large genomic deletions delineate Mycobacterium tuberculosis L4 sublineages in South American countries.
    PLoS One. 2023;18:e0285417.
    PubMed     Abstract available


  274. MAIN S, Triasih R, Greig J, Hidayat A, et al
    The prevalence and risk factors for tuberculosis among healthcare workers in Yogyakarta, Indonesia.
    PLoS One. 2023;18:e0279215.
    PubMed     Abstract available


  275. AKALU TY, Clements ACA, Baraki AG, Alene KA, et al
    Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis.
    PLoS One. 2023;18:e0285404.
    PubMed     Abstract available


  276. KAMBLE S, Shidhaye P, Mukherjee A, Tak M, et al
    A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    PLoS One. 2023;18:e0285942.
    PubMed     Abstract available


  277. HASAN MZ, Ahmed S, Islam Z, Dorin F, et al
    Costs of services and funding gap of the Bangladesh National Tuberculosis Control Programme 2016-2022: An ingredient based approach.
    PLoS One. 2023;18:e0286560.
    PubMed     Abstract available


  278. D FREIRE I, L Fielding K, A J Moore D
    Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?
    PLoS One. 2023;18:e0286306.
    PubMed     Abstract available


  279. SHARANI ZZ, Ismail N, Yasin SM, Isa MR, et al
    T-BACCO SCORE: A predictive scoring tool for tuberculosis (TB) loss to follow-up among TB smokers.
    PLoS One. 2023;18:e0287374.
    PubMed     Abstract available


  280. BAATJIES L, van Rensberg IC, Snyders C, Gutschmidt A, et al
    Investigating Mycobacterium tuberculosis sufR (rv1460) in vitro and ex vivo expression and immunogenicity.
    PLoS One. 2023;18:e0286965.
    PubMed     Abstract available


  281. ALEMU A, Bitew ZW, Diriba G, Seid G, et al
    Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286194.
    PubMed     Abstract available


  282. KAGUJJE M, Nyangu S, Maimbolwa MM, Shuma B, et al
    Strategies to increase childhood tuberculosis case detection at the primary health care level: Lessons from an active case finding study in Zambia.
    PLoS One. 2023;18:e0288643.
    PubMed     Abstract available


  283. FEKADU G, Wang Y, You JHS
    Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
    PLoS One. 2023;18:e0288605.
    PubMed     Abstract available


  284. PONGMA C, Songthammanuphap S, Puthong S, Buakeaw A, et al
    Using whole blood cultures in interferon gamma release assays to detect Mycobacterium tuberculosis complex infection in Asian elephants (Elephas maximus).
    PLoS One. 2023;18:e0288161.
    PubMed     Abstract available


  285. GEORGE S, Syamala TS, Paranjpe A, Saalim M, et al
    Intersections of informal work status, gender and tuberculosis diagnosis: Insights from a qualitative study from an Indian setting.
    PLoS One. 2023;18:e0289137.
    PubMed     Abstract available


  286. XIE M, Tsai CY, McAdams ZL, Oo M, et al
    Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice.
    PLoS One. 2023;18:e0288290.
    PubMed     Abstract available


  287. MEKONNEN E, Arega M, Belay DM, Birhanu D, et al
    Time to death and its predictors among under-five children on antiretroviral treatment in public hospitals of Addis Ababa, Addis Ababa, Ethiopia, a retrospective follow up study.
    PLoS One. 2023;18:e0288475.
    PubMed     Abstract available


  288. KURTZ SL, Ryden P, Elkins KL
    Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
    PLoS One. 2023;18:e0289358.
    PubMed     Abstract available


  289. KABORE OD, Millogo A, Sanogo B, Birba E, et al
    Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country.
    PLoS One. 2023;18:e0288671.
    PubMed     Abstract available


  290. MOLLALIGN H, Getahun M, Diriba G, Alemu A, et al
    Genetic diversity and drug sensitivity profile of Mycobacterium tuberculosis among children in Ethiopia.
    PLoS One. 2023;18:e0284363.
    PubMed     Abstract available


  291. LOLONG DB, Aryastami NK, Kusrini I, Tobing KL, et al
    Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia.
    PLoS One. 2023;18:e0287628.
    PubMed     Abstract available


  292. KATAMBA A, Ssengooba W, Sserubiri J, Semugenze D, et al
    Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
    PLoS One. 2023;18:e0284545.
    PubMed     Abstract available


  293. BERROCAL-ALMANZA LC, Lima M, Piotrowski H, Botticello J, et al
    Vulnerability and tuberculosis treatment outcomes in urban settings in England: A mixed-methods study.
    PLoS One. 2023;18:e0281918.
    PubMed     Abstract available


  294. GARG T, Nonyane BAS, Mohlamonyane M, Lebina L, et al
    Investigating linkage to care between hospitals and primary care clinics for people with TB in rural South Africa.
    PLoS One. 2023;18:e0289830.
    PubMed     Abstract available


  295. MASSUD A, Khan AH, Syed Sulaiman SA, Ahmad N, et al
    Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
    PLoS One. 2023;18:e0287966.
    PubMed     Abstract available


  296. SEJIE GA, Mahomed OH
    Potential facilitators and inhibitors to the implementation and sustainability of the community-based tuberculosis care interventions. A case study from Moshupa, Botswana.
    PLoS One. 2023;18:e0290010.
    PubMed     Abstract available


  297. MALECHE-OBIMBO E, Attia E, Were F, Jaoko W, et al
    Prevalence, clinical presentation and factors associated with chronic lung disease among children and adolescents living with HIV in Kenya.
    PLoS One. 2023;18:e0289756.
    PubMed     Abstract available


  298. MALHOTRA A, Thompson R, De Vos M, David A, et al
    Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
    PLoS One. 2023;18:e0290496.
    PubMed     Abstract available


  299. MEESAWAT S, Aiempichitkijkarn N, Warit S, Kaewparuehaschai M, et al
    Non-invasive specimen collections for Mycobacterium tuberculosis detection in free-ranging long-tailed macaques (Macaca fascicularis).
    PLoS One. 2023;18:e0289961.
    PubMed     Abstract available


  300. AUNG PL, Win KM, Win Maung HM, Show KL, et al
    Determinants of correct knowledge on tuberculosis transmission and self-reported tuberculosis prevalence among general population aged 15-49 years in Myanmar.
    PLoS One. 2023;18:e0290470.
    PubMed     Abstract available


  301. LERTUDOMPHONWANIT T, Somboonprasert C, Lilakhunakon K, Jaovisidha S, et al
    A clinical prediction model to differentiate tuberculous spondylodiscitis from pyogenic spontaneous spondylodiscitis.
    PLoS One. 2023;18:e0290361.
    PubMed     Abstract available


  302. MOTTA CP, Olimpio da Silva DL, da Costa LR, Galhardo GF, et al
    Performance during the Glittre-ADL test between patients with and without post-tuberculosis bronchiectasis: A cross-sectional study.
    PLoS One. 2023;18:e0290850.
    PubMed     Abstract available


  303. MA Z, Fan H
    Influential factors of tuberculosis in mainland China based on MGWR model.
    PLoS One. 2023;18:e0290978.
    PubMed     Abstract available


  304. PEREZ-RECIO S, Grijota-Camino MD, Anibarro L, Rabunal-Rey R, et al
    Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.
    PLoS One. 2023;18:e0285917.
    PubMed     Abstract available


  305. RAMSAY LC, Marina Richardson, Miranda RN, Hassan M, et al
    Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review.
    PLoS One. 2023;18:e0290710.
    PubMed     Abstract available


  306. GETAHUN DA, Layland LE, Hoerauf A, Wondale B, et al
    Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years.
    PLoS One. 2023;18:e0289917.
    PubMed     Abstract available


  307. TOK PSK, Wong LP, Liew SM, Razali A, et al
    A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia.
    PLoS One. 2023;18:e0289222.
    PubMed     Abstract available


  308. TORNU E, Jordan P, McCaul M
    Best practice guidelines for professional nurses to provide self-management support to adults with tuberculosis-human immunodeficiency virus coinfection: A scoping review.
    PLoS One. 2023;18:e0291529.
    PubMed     Abstract available


  309. SIBHAT MM, Mulugeta TN, Aklilu DW
    Incidence of switching to second-line antiretroviral therapy and its predictors among children on antiretroviral therapy at general hospitals, Northern Ethiopia: A survival analysis.
    PLoS One. 2023;18:e0288132.
    PubMed     Abstract available


  310. KARANJA S, Aduda J, Thuo R, Wamunyokoli F, et al
    Utilization of digital tools to enhance COVID-19 and tuberculosis testing and linkage to care: A cross-sectional evaluation study among Bodaboda motorbike riders in the Nairobi Metropolis, Kenya.
    PLoS One. 2023;18:e0290575.
    PubMed     Abstract available


  311. TILAHUN M, Wegayehu T, Wondale B, Gebresilase TT, et al
    Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    PLoS One. 2023;18:e0285063.
    PubMed     Abstract available


  312. ROMANOWSKI K, Karim ME, Gilbert M, Cook VJ, et al
    Distinct healthcare utilization profiles of high healthcare use tuberculosis survivors: A latent class analysis.
    PLoS One. 2023;18:e0291997.
    PubMed     Abstract available


  313. TEKESE D, Dawit D, Hawulte B, Mohammed H, et al
    Incidence and predictors of tuberculosis among children receiving antiretroviral therapy in the Wolaita Zone: A retrospective cohort study.
    PLoS One. 2023;18:e0291502.
    PubMed     Abstract available


  314. EREM G, Otike C, Okuja M, Ameda F, et al
    Diagnostic accuracy of chest ultrasound scan in the diagnosis of childhood tuberculosis.
    PLoS One. 2023;18:e0287621.
    PubMed     Abstract available


  315. OSEI E, Amu H, Kye-Duodu G, Kwabla MP, et al
    Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.
    PLoS One. 2023;18:e0291808.
    PubMed     Abstract available


  316. ISLAM MS, Gurley ES, Banu S, Hossain K, et al
    Prevalence and incidence of tuberculosis infection among healthcare workers in chest diseases hospitals, Bangladesh: Putting infection control into context.
    PLoS One. 2023;18:e0291484.
    PubMed     Abstract available


  317. WINTERS N, Schnitzer ME, Campbell JR, Ripley S, et al
    Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
    PLoS One. 2023;18:e0292106.
    PubMed     Abstract available


  318. ZERIHUN M, Mekonnen H, Gebretensaye TG
    Treatment outcome and associated factors among adult patients with pulmonary tuberculosis in selected health centers in Addis Ababa Ethiopia.
    PLoS One. 2023;18:e0292218.
    PubMed     Abstract available


  319. CHAWLA K, Burugina Nagaraja S, Siddalingaiah N, Sanju C, et al
    Tuberculosis screening for pediatric household contacts in India: Time to adapt newer strategies under the National TB Elimination Programme!
    PLoS One. 2023;18:e0292387.
    PubMed     Abstract available


  320. MOENS C, Filee P, Boes A, Alie C, et al
    Identification of New Mycobacterium bovis antigens and development of a multiplexed serological bead-immunoassay for the diagnosis of bovine tuberculosis in cattle.
    PLoS One. 2023;18:e0292590.
    PubMed     Abstract available


  321. VERBOVEN L, Phelan J, Heupink TH, Van Rie A, et al
    Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis.
    PLoS One. 2023;18:e0293254.
    PubMed     Abstract available


  322. MEJIA-PONCE PM, Ramos-Gonzalez EJ, Ramos-Garcia AA, Lara-Ramirez EE, et al
    Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico.
    PLoS One. 2023;18:e0292965.
    PubMed     Abstract available


  323. MUSHTAQ F, Raza SM, Ahmad A, Aslam H, et al
    Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
    PLoS One. 2023;18:e0293194.
    PubMed     Abstract available


  324. HAVUMAKI J, Warren JL, Zelner J, Menzies NA, et al
    Spatially-targeted tuberculosis screening has limited impact beyond household contact tracing in Lima, Peru: A model-based analysis.
    PLoS One. 2023;18:e0293519.
    PubMed     Abstract available


  325. MANDO TC, Sandy C, Chadambuka A, Gombe NT, et al
    Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
    PLoS One. 2023;18:e0293867.
    PubMed     Abstract available


  326. VERMA-KUMAR S, Abraham D, Dendukuri N, Cheeran JV, et al
    Correction: Serodiagnosis of Tuberculosis in Asian Elephants (Elephas maximus) in Southern India: A Latent Class Analysis.
    PLoS One. 2023;18:e0294550.
    PubMed     Abstract available


  327. GRAY AT, Macpherson L, Carlin F, Sossen B, et al
    Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293535.
    PubMed     Abstract available


  328. SHIN HJ, Yoon JY, Na YO, Lee JK, et al
    Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.
    PLoS One. 2023;18:e0294490.
    PubMed     Abstract available


  329. YANG Y, Liu L, Yang X, Li L, et al
    Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016-2020.
    PLoS One. 2023;18:e0280578.
    PubMed     Abstract available


  330. MAYITO J, Meya DB, Miriam A, Dhikusooka F, et al
    Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
    PLoS One. 2023;18:e0291834.
    PubMed     Abstract available


  331. TRIVEDI P, Chaturvedi V
    Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
    PLoS One. 2023;18:e0292397.
    PubMed     Abstract available


  332. AFFUL P, Vechey GA, Leta PK, Gbafu FB, et al
    Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.
    PLoS One. 2023;18:e0294928.
    PubMed     Abstract available


  333. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis.
    PLoS One. 2023;18:e0289336.
    PubMed     Abstract available


  334. SPRUIJT I, Alam Y, Nguyen H, Myrzaliev B, et al
    Digital health solutions and integrated COVID-19 and TB services to help recover TB care and prevention services in the COVID-19 pandemic: A descriptive study in four high TB burden countries.
    PLoS One. 2023;18:e0293964.
    PubMed     Abstract available


  335. MOREY-LEON G, Mejia-Ponce PM, Granda Pardo JC, Munoz-Mawyin K, et al
    A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
    PLoS One. 2023;18:e0294670.
    PubMed     Abstract available


  336. BONGOMIN F, Olum R, Kibone W, Namusobya M, et al
    Prevalence of chronic pulmonary aspergillosis along the continuum of pulmonary tuberculosis care: A protocol for a living systematic review and meta-analysis.
    PLoS One. 2023;18:e0294634.
    PubMed     Abstract available


  337. KWAK SH, Jeong D, Mok J, Jeon D, et al
    Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study.
    PLoS One. 2023;18:e0295556.
    PubMed     Abstract available


  338. NOIA MACIEL EL, Negri LDSA, Guidoni LM, Fregona GC, et al
    The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
    PLoS One. 2023;18:e0287961.
    PubMed     Abstract available


  339. TIRUNEH MG, Fenta ET, Anagaw TF, Bogale EK, et al
    Tuberculosis infection control practice and associated factors among health care workers in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0295555.
    PubMed     Abstract available


  340. SCIAUDONE M, Carpena R, Calderon M, Sheen P, et al
    Rapid detection of Mycobacterium tuberculosis using recombinase polymerase amplification: A pilot study.
    PLoS One. 2023;18:e0295610.
    PubMed     Abstract available


  341. ODONGO D, Omech B, Acanga A
    Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
    PLoS One. 2023;18:e0288761.
    PubMed     Abstract available


  342. GIRIDHARAN P, Selvaraju S, Rao R, Rade K, et al
    Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey.
    PLoS One. 2023;18:e0294254.
    PubMed     Abstract available


  343. JAMIL B, Nair D, Thekkur P, Laeeq N, et al
    Feasibility, enablers and challenges of using timeliness metrics for household contact tracing and TB preventive therapy in Pakistan.
    PLoS One. 2023;18:e0295580.
    PubMed     Abstract available


  344. MACGREGOR-FAIRLIE M, De Gomes P, Weston D, Rickard JJS, et al
    Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales.
    PLoS One. 2023;18:e0293093.
    PubMed     Abstract available


  345. ATRE S, Jagtap J, Faqih M, Dumbare Y, et al
    Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India.
    PLoS One. 2023;18:e0295508.
    PubMed     Abstract available


  346. GILS T, Kamele M, Madonsela T, Bosman S, et al
    Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    PLoS One. 2023;18:e0296197.
    PubMed     Abstract available


    January 2021
  347. LANSANG MAD, Alejandria MM, Law I, Juban NR, et al
    High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey.
    PLoS One. 2021;16:e0252240.
    PubMed     Abstract available


  348. TAMUHLA T, Dave JA, Raubenheimer P, Tiffin N, et al
    Diabetes in a TB and HIV-endemic South African population: Analysis of a virtual cohort using routine health data.
    PLoS One. 2021;16:e0251303.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.